Zymeworks Inc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 5 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	29 Apr 2019	Lorem
VAR2 seeks toxin/conjugation CDMO for preclinical malaria protein-based oncology pipeline, partnering talks underway -- COO	08 Nov 2017	Fiona Barry
Zymeworks plans INDs in June and December for HER2-targeted antibodies, CEO says	31 May 2016	Manasi Vaidya
Zymeworks seeks USD 50m in capital raise, to reach IPO decision in autumn - CEO	01 Apr 2015	Katie McQue

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Zymeworks Inc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer